[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
[ Thu, Aug 10th 2023 ]: WOPRAI
Matthew Harrison Maintained (TNYA) at Buy with Increased Target to $14 on, Aug 10th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Maintained "Tenaya Therapeutics, Inc." (TNYA) at Buy with Increased Target from $13 to $14 on, Aug 10th, 2023.
Matthew has made no other calls on TNYA in the last 4 months.
There is 1 other peer that has a rating on TNYA. Out of the 1 peers that are also analyzing TNYA, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $23 on, Friday, May 12th, 2023